Brainsway

Brainsway Net Margin

The Net Profit Margin of Brainsway (BWAY.TA) as of Oct 22, 2026 is 14.62 %. In the previous year, Net Profit Margin was 7.12 % — a change of 105.23% (higher).

Net Margin

14.62 %

YoY

105.23%

Last updated:

Net Profit Margin of Brainsway is 2025 14.62 % . Net Profit Margin of Brainsway was 2024 7.12 % . It decreases by 105.23% higher compared to the previous year.

Brainsway's net margin stands at 14.6%, up from -21.8% several years earlier.

The Brainsway Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-39.51 USD
Jan 1, 2019
-44.71 USD
Jan 1, 2020
-24.41 USD
Jan 1, 2021
-21.79 USD
Jan 1, 2022
-49.12 USD
Jan 1, 2023
-13.20 USD
Jan 1, 2024
7.12 USD
Jan 1, 2025
14.62 USD
The Brainsway Net Margin history
YEARNet MarginYoY
14.62 %+105.23%
7.12 %-153.93%
-13.20 %-73.12%
-49.12 %+125.43%
-21.79 %-10.75%
-24.41 %-45.39%
-44.71 %+13.15%
-39.51 %-37.57%
-63.29 %+204.29%
-20.80 %-65.39%
-60.10 %-68.96%
-193.64 %+3,132.76%
-5.99 %-63.12%
-16.24 %-35.70%
-25.26 %+99.42%
-12.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brainsway Stock analysis

What does Brainsway do? Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brainsway stock

Net Profit Margin of Brainsway is 14.62 % in 2025.

Net Profit Margin of Brainsway changed from 7.12 % to 14.62 %, representing a 105.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Brainsway since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Brainsway with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Brainsway

All Key Metrics — Brainsway